احصل على
Contribute to hedaokuan/fr development by creating an account on GitHub
2024年2月1日 Key growth drivers of the Roche portfolio in 2023 12 FY 2023 sales (YoY CER growth) +2%13% (+7%)* Definition of Pharmaceuticals TA split used in the FY 2023 Financial Report vs IR Presentation explained on slide 172; *Diagnostics base business growth at +7% Diagnostics: +7% base business growth Vabysmo
Measuring mode ISE indirect: Application for serum and plasma: Na+ 80‐180 mmol/L K+ 15‐100 mmol/L Cl 60‐140 mmol/L Analysis of sodium on a cobas c system with serum and plasma specimens should yield a linear relationship from 80‐180 mmol/L with a deviation from the linear line of less than 5 %
2021年12月10日 Roche launches first inhouse accelerator globally in Shanghai to empower local healthcare innovation ecosystem (May 18, 2021, Shanghai, China) The Roche Accelerator was officially launched today at the Roche campus in Zhangjiang Hightech Park, Shanghai At the launch ceremony, Roche signed strategic
3 天之前 At Roche we deliver a broad and growing selection of advanced research tools that accelerate life science discovery Committed to innovation, quality, and service, we offer an extensive product portfolio featuring cuttingedge instruments and reagents for genome sequencing, microarray analysis, nucleic acid purification, real
6 天之前 Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of invitro diagnostics and a global supplier of transformative innovative solutions across major disease areas
About us Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives The combined strengths of pharmaceuticals and diagnostics under one
6 天之前 样本直接在医生办公室或实验室进行分析，罗氏则提供测试与仪器 我们的大多数体外测试都在罗氏或与外部合作伙伴共同开发和制造的诊断仪器上进行。 其中一些仪器很小，用于分析患者的血液或尿液。 您可以在医生办公室和医院科室找到它们。
6 天之前 Roche Group Innovation Engines Having Diagnostics and Pharma in one company is a powerful advantage that sets Roche apart RDS is researching and developing comprehensive endtoend diagnostics solutions to address the needs of labs and Points of Care RIS is researching and developing digital solutions to help
3 天之前 罗氏诊断是罗氏集团重要的业务之一。 罗氏不仅致力于不断改善疾病诊断的解决方案，以辅助医疗专业人士为患者健康做出关键决策，还将不断改善这些重要工具融入全球卫生系统的方式，以期实现以更低的成本，达到最佳效果。 在100多个国家和
Contribute to hedaokuan/fr development by creating an account on GitHub
2024年2月1日 Key growth drivers of the Roche portfolio in 2023 12 FY 2023 sales (YoY CER growth) +2%13% (+7%)* Definition of Pharmaceuticals TA split used in the FY 2023 Financial Report vs IR Presentation explained on slide 172; *Diagnostics base business growth at +7% Diagnostics: +7% base business growth Vabysmo
Measuring mode ISE indirect: Application for serum and plasma: Na+ 80‐180 mmol/L K+ 15‐100 mmol/L Cl 60‐140 mmol/L Analysis of sodium on a cobas c system with serum and plasma specimens should yield a linear relationship from 80‐180 mmol/L with a deviation from the linear line of less than 5 %
2021年12月10日 Roche launches first inhouse accelerator globally in Shanghai to empower local healthcare innovation ecosystem (May 18, 2021, Shanghai, China) The Roche Accelerator was officially launched today at the Roche campus in Zhangjiang Hightech Park, Shanghai At the launch ceremony, Roche signed strategic
3 天之前 At Roche we deliver a broad and growing selection of advanced research tools that accelerate life science discovery Committed to innovation, quality, and service, we offer an extensive product portfolio featuring cuttingedge instruments and reagents for genome sequencing, microarray analysis, nucleic acid purification, real
6 天之前 Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of invitro diagnostics and a global supplier of transformative innovative solutions across major disease areas
About us Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives The combined strengths of pharmaceuticals and diagnostics under one
6 天之前 样本直接在医生办公室或实验室进行分析，罗氏则提供测试与仪器 我们的大多数体外测试都在罗氏或与外部合作伙伴共同开发和制造的诊断仪器上进行。 其中一些仪器很小，用于分析患者的血液或尿液。 您可以在医生办公室和医院科室找到它们。
6 天之前 Roche Group Innovation Engines Having Diagnostics and Pharma in one company is a powerful advantage that sets Roche apart RDS is researching and developing comprehensive endtoend diagnostics solutions to address the needs of labs and Points of Care RIS is researching and developing digital solutions to help
3 天之前 罗氏诊断是罗氏集团重要的业务之一。 罗氏不仅致力于不断改善疾病诊断的解决方案，以辅助医疗专业人士为患者健康做出关键决策，还将不断改善这些重要工具融入全球卫生系统的方式，以期实现以更低的成本，达到最佳效果。 在100多个国家和
Contribute to hedaokuan/fr development by creating an account on GitHub
2024年2月1日 Key growth drivers of the Roche portfolio in 2023 12 FY 2023 sales (YoY CER growth) +2%13% (+7%)* Definition of Pharmaceuticals TA split used in the FY 2023 Financial Report vs IR Presentation explained on slide 172; *Diagnostics base business growth at +7% Diagnostics: +7% base business growth Vabysmo
Measuring mode ISE indirect: Application for serum and plasma: Na+ 80‐180 mmol/L K+ 15‐100 mmol/L Cl 60‐140 mmol/L Analysis of sodium on a cobas c system with serum and plasma specimens should yield a linear relationship from 80‐180 mmol/L with a deviation from the linear line of less than 5 %
2021年12月10日 Roche launches first inhouse accelerator globally in Shanghai to empower local healthcare innovation ecosystem (May 18, 2021, Shanghai, China) The Roche Accelerator was officially launched today at the Roche campus in Zhangjiang Hightech Park, Shanghai At the launch ceremony, Roche signed strategic
3 天之前 At Roche we deliver a broad and growing selection of advanced research tools that accelerate life science discovery Committed to innovation, quality, and service, we offer an extensive product portfolio featuring cuttingedge instruments and reagents for genome sequencing, microarray analysis, nucleic acid purification, real
6 天之前 Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of invitro diagnostics and a global supplier of transformative innovative solutions across major disease areas
About us Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives The combined strengths of pharmaceuticals and diagnostics under one
6 天之前 样本直接在医生办公室或实验室进行分析，罗氏则提供测试与仪器 我们的大多数体外测试都在罗氏或与外部合作伙伴共同开发和制造的诊断仪器上进行。 其中一些仪器很小，用于分析患者的血液或尿液。 您可以在医生办公室和医院科室找到它们。
6 天之前 Roche Group Innovation Engines Having Diagnostics and Pharma in one company is a powerful advantage that sets Roche apart RDS is researching and developing comprehensive endtoend diagnostics solutions to address the needs of labs and Points of Care RIS is researching and developing digital solutions to help
3 天之前 罗氏诊断是罗氏集团重要的业务之一。 罗氏不仅致力于不断改善疾病诊断的解决方案，以辅助医疗专业人士为患者健康做出关键决策，还将不断改善这些重要工具融入全球卫生系统的方式，以期实现以更低的成本，达到最佳效果。 在100多个国家和
Contribute to hedaokuan/fr development by creating an account on GitHub
2024年2月1日 Key growth drivers of the Roche portfolio in 2023 12 FY 2023 sales (YoY CER growth) +2%13% (+7%)* Definition of Pharmaceuticals TA split used in the FY 2023 Financial Report vs IR Presentation explained on slide 172; *Diagnostics base business growth at +7% Diagnostics: +7% base business growth Vabysmo
Measuring mode ISE indirect: Application for serum and plasma: Na+ 80‐180 mmol/L K+ 15‐100 mmol/L Cl 60‐140 mmol/L Analysis of sodium on a cobas c system with serum and plasma specimens should yield a linear relationship from 80‐180 mmol/L with a deviation from the linear line of less than 5 %
2021年12月10日 Roche launches first inhouse accelerator globally in Shanghai to empower local healthcare innovation ecosystem (May 18, 2021, Shanghai, China) The Roche Accelerator was officially launched today at the Roche campus in Zhangjiang Hightech Park, Shanghai At the launch ceremony, Roche signed strategic
3 天之前 At Roche we deliver a broad and growing selection of advanced research tools that accelerate life science discovery Committed to innovation, quality, and service, we offer an extensive product portfolio featuring cuttingedge instruments and reagents for genome sequencing, microarray analysis, nucleic acid purification, real
6 天之前 Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of invitro diagnostics and a global supplier of transformative innovative solutions across major disease areas
About us Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives The combined strengths of pharmaceuticals and diagnostics under one
6 天之前 样本直接在医生办公室或实验室进行分析，罗氏则提供测试与仪器 我们的大多数体外测试都在罗氏或与外部合作伙伴共同开发和制造的诊断仪器上进行。 其中一些仪器很小，用于分析患者的血液或尿液。 您可以在医生办公室和医院科室找到它们。
6 天之前 Roche Group Innovation Engines Having Diagnostics and Pharma in one company is a powerful advantage that sets Roche apart RDS is researching and developing comprehensive endtoend diagnostics solutions to address the needs of labs and Points of Care RIS is researching and developing digital solutions to help
3 天之前 罗氏诊断是罗氏集团重要的业务之一。 罗氏不仅致力于不断改善疾病诊断的解决方案，以辅助医疗专业人士为患者健康做出关键决策，还将不断改善这些重要工具融入全球卫生系统的方式，以期实现以更低的成本，达到最佳效果。 在100多个国家和
Contribute to hedaokuan/fr development by creating an account on GitHub
2024年2月1日 Key growth drivers of the Roche portfolio in 2023 12 FY 2023 sales (YoY CER growth) +2%13% (+7%)* Definition of Pharmaceuticals TA split used in the FY 2023 Financial Report vs IR Presentation explained on slide 172; *Diagnostics base business growth at +7% Diagnostics: +7% base business growth Vabysmo
Measuring mode ISE indirect: Application for serum and plasma: Na+ 80‐180 mmol/L K+ 15‐100 mmol/L Cl 60‐140 mmol/L Analysis of sodium on a cobas c system with serum and plasma specimens should yield a linear relationship from 80‐180 mmol/L with a deviation from the linear line of less than 5 %
2021年12月10日 Roche launches first inhouse accelerator globally in Shanghai to empower local healthcare innovation ecosystem (May 18, 2021, Shanghai, China) The Roche Accelerator was officially launched today at the Roche campus in Zhangjiang Hightech Park, Shanghai At the launch ceremony, Roche signed strategic
3 天之前 At Roche we deliver a broad and growing selection of advanced research tools that accelerate life science discovery Committed to innovation, quality, and service, we offer an extensive product portfolio featuring cuttingedge instruments and reagents for genome sequencing, microarray analysis, nucleic acid purification, real
6 天之前 Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of invitro diagnostics and a global supplier of transformative innovative solutions across major disease areas
About us Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives The combined strengths of pharmaceuticals and diagnostics under one
6 天之前 样本直接在医生办公室或实验室进行分析，罗氏则提供测试与仪器 我们的大多数体外测试都在罗氏或与外部合作伙伴共同开发和制造的诊断仪器上进行。 其中一些仪器很小，用于分析患者的血液或尿液。 您可以在医生办公室和医院科室找到它们。
6 天之前 Roche Group Innovation Engines Having Diagnostics and Pharma in one company is a powerful advantage that sets Roche apart RDS is researching and developing comprehensive endtoend diagnostics solutions to address the needs of labs and Points of Care RIS is researching and developing digital solutions to help
3 天之前 罗氏诊断是罗氏集团重要的业务之一。 罗氏不仅致力于不断改善疾病诊断的解决方案，以辅助医疗专业人士为患者健康做出关键决策，还将不断改善这些重要工具融入全球卫生系统的方式，以期实现以更低的成本，达到最佳效果。 在100多个国家和
